- Home
- MAX vs ORIC Comparison
MAX vs ORIC Comparison
Compare MAX & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAX | ORIC |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.8M | 1.2B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MAX | ORIC |
|---|---|---|
| Price | $9.64 | $10.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 13 |
| Target Price | $14.58 | ★ $20.00 |
| AVG Volume (30 Days) | 971.5K | ★ 1.4M |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.81 | 19.67 |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,113,600,000.00 | N/A |
| Revenue This Year | $12.70 | N/A |
| Revenue Next Year | $9.32 | N/A |
| P/E Ratio | $24.90 | ★ N/A |
| Revenue Growth | ★ 28.78 | N/A |
| 52 Week Low | $7.09 | $3.90 |
| 52 Week High | $13.92 | $14.93 |
Technical Indicators
Market Signals| Indicator | MAX | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 40.94 |
| Support Level | $9.45 | $9.88 |
| Resistance Level | $10.93 | $12.12 |
| Average True Range (ATR) | 0.43 | 0.83 |
| MACD | 0.02 | -0.31 |
| Stochastic Oscillator | 22.55 | 7.46 |
Price Performance
Historical ComparisonAbout MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.